Galantamine versus donepezil in Chinese patients with Alzheimer&rsquo;s disease: results from a randomized, double-blind study

Código QR

Galantamine versus donepezil in Chinese patients with Alzheimer&rsquo;s disease: results from a randomized, double-blind study

Zhenxin Zhang,1 Lu Yu,2 Maren Gaudig,3 Barbara Sch&auml;uble,4 Ute Richarz51Department of Neurology of Peking Union Medical College Hospital, 2Xi&rsquo;an Janssen Pharmaceutical Ltd, Beijing, China; 3Health Economics and Reimbursement, Janssen-Cilag EMEA, Neuss, Germany; 4Formerly of...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Zhang Z, Yu L, Gaudig M, Sch&auml;uble B, Richarz U
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2012
Materias:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/b620cc77952f4258a172e5bc06a4d168
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Clinically meaningful treatment responses after switching to galantamine and with addition of memantine in patients with Alzheimer&rsquo;s disease receiving donepezil
por: Kano O, et al.
Publicado: (2013)

Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer’s disease: A systematic review and meta-analysis
por: Richard A Hansen, et al.
Publicado: (2008)

Galantamine-ER for the treatment of mild-to-moderate Alzheimer’s disease
por: Ben Seltzer
Publicado: (2009)

Clinical efficacy and safety of donepezil in the treatment of Alzheimer’s disease in Chinese patients
por: Zhang N, et al.
Publicado: (2018)

Galantamine treatment in Alzheimer&#39;s disease: response and long-term outcome in a routine clinical setting
por: Wallin &Aring;K, et al.
Publicado: (2011)

Effects of galantamine in a 2-year, randomized, placebo-controlled study in Alzheimer’s disease [Corrigendum]
por: Hager K, et al.
Publicado: (2014)

Use of Methylphenidate in Excessive Daytime Sleepiness in Alzheimer’s Patients Treated with Donepezil: Case Series
por: Bidzan L, et al.
Publicado: (2020)

An update on the toxicity of A&beta; in Alzheimer&rsquo;s disease
por: J&uuml;rgen G&ouml;tz, et al.
Publicado: (2008)

Ceruloplasmin and iron in Alzheimer&rsquo;s disease and Parkinson&rsquo;s disease: a synopsis of recent studies
por: Kristinsson J, et al.
Publicado: (2012)

Long-term effect of galantamine on cognitive function in patients with Alzheimer’s disease versus a simulated disease trajectory: an observational study in the clinical setting
por: Nakagawa R, et al.
Publicado: (2017)

A randomized, 4-week double-blind placebo control study on the efficacy of donepezil augmentation of lithium for treatment of acute mania
por: Chen J, et al.
Publicado: (2013)

Two cases of Alzheimer&#39;s disease showing deterioration of behavioral and psychological symptoms of dementia induced by switching from rivastigmine to donepezil
por: Kimura T, et al.
Publicado: (2012)

Influence of rs1080985 single nucleotide polymorphism of the CYP2D6 gene on response to treatment with donepezil in patients with Alzheimer’s disease
por: Klimkowicz-Mrowiec A, et al.
Publicado: (2013)

Formulation optimization of galantamine hydrobromide loaded gel drug reservoirs in transdermal patch for Alzheimer’s disease
por: Woo FY, et al.
Publicado: (2015)

Update on the use of memantine in Alzheimer&rsquo;s disease
por: Robert J van Marum
Publicado: (2009)

Brain amyloid &beta; protein and memory disruption in Alzheimer&rsquo;s disease
por: Weiming Xia
Publicado: (2010)

Impact of Plasma Donepezil Concentration on Behavioral and Psychological Symptoms of Dementia in Patients with Alzheimer’s Disease
por: Yoshiyuki Kagawa, et al.
Publicado: (2021)

A review of the potential therapeutic role of statins in the treatment of Alzheimer&rsquo;s disease: current research and opinion
por: Mitchell AJ, et al.
Publicado: (2013)

Intrathecal corticosteroids might slow Alzheimer&rsquo;s disease progression
por: Joseph Martin Alisky
Publicado: (2008)

Present and prospective clinical therapeutic regimens for Alzheimer&rsquo;s disease
por: Mustafa M Husain, et al.
Publicado: (2008)

Memantine treatment for Japanese patients with moderate to severe Alzheimer’s disease: a meta-analysis of double-blind, randomized, placebo-controlled trials
por: Kishi T, et al.
Publicado: (2018)

Errorless learning and spaced retrieval techniques to relearn instrumental activities of daily living in mild Alzheimer&rsquo;s disease: A case report study
por: St&eacute;phanie Thivierge, et al.
Publicado: (2008)

Optimal management of Alzheimer&rsquo;s disease patients: Clinical guidelines and family advice
por: Julia Haberstroh, et al.
Publicado: (2010)

Effectiveness and tolerability of transdermal rivastigmine in the treatment of Alzheimer&rsquo;s disease in daily practice
por: Seibert J, et al.
Publicado: (2012)

Could lysine supplementation prevent Alzheimer&rsquo;s dementia? A novel hypothesis
por: Robert N Rubey
Publicado: (2010)

Parkinson&rsquo;s disease patients&rsquo; subjective descriptions of characteristics of chronic pain, sleeping patterns and health-related quality of life
por: Skogar &Ouml;, et al.
Publicado: (2012)

Brain ischemia and ischemic blood&ndash;brain barrier as etiological factors in sporadic Alzheimer&rsquo;s disease
por: Ryszard Pluta, et al.
Publicado: (2008)

Double-blind comparison of ziprasidone and risperidone in the treatment of Chinese patients with acute exacerbation of schizophrenia
por: Hongyan Zhang, et al.
Publicado: (2011)

Reproductive life events and Alzheimer&rsquo;s disease in Italian women: a retrospective study
por: Bono G, et al.
Publicado: (2012)

Prolonged cholinergic enrichment influences regional cortical activation in early Alzheimer&rsquo;s disease
por: William J McGeown, et al.
Publicado: (2008)

Menatetrenone versus alfacalcidol in the treatment of Chinese postmenopausal women with osteoporosis: a multicenter, randomized, double-blinded, double-dummy, positive drug-controlled clinical trial
por: Jiang Y, et al.
Publicado: (2014)

Critical appraisal of the long-term impact of memantine in treatment of moderate to severe Alzheimer&rsquo;s disease
por: Umamon Puangthong, et al.
Publicado: (2009)

Estrogen receptor-mediated neuroprotection: The role of the Alzheimer&rsquo;s disease-related gene seladin-1
por: Alessandro Peri, et al.
Publicado: (2008)

Neuroinflammation in Alzheimer’s disease
por: Zhang FJ, et al.
Publicado: (2015)

Diffusion tensor imaging investigations in Alzheimer&rsquo;s disease: the resurgence of white matter compromise in&nbsp;the cortical dysfunction of the aging brain
por: David A Medina, et al.
Publicado: (2008)

Functional imaging of hippocampal dysfunction among persons with Alzheimer&rsquo;s disease: a proof-of-concept study
por: David B Arciniegas, et al.
Publicado: (2010)

Did depressive symptoms affect recognition of emotional prosody in Parkinson&rsquo;s disease?
por: Adriana V&eacute;lez Feij&oacute;, et al.
Publicado: (2008)

Neuroinflammation and tumor necrosis factor signaling in the pathophysiology of Alzheimer&rsquo;s disease
por: Fiona E McAlpine, et al.
Publicado: (2008)

Neuroanatomical abnormalities before onset of delusions in patients with Alzheimer&rsquo;s disease: a voxel-based morphometry study
por: Nakaaki S, et al.
Publicado: (2012)

The efficacy of mirtazapine in agitated patients with Alzheimer&rsquo;s disease: A 12-week open-label pilot study
por: Sibel Cakir, et al.
Publicado: (2008)